EIF4A3 and cancer: Higher expression of EIF4A3 was significantly associated with a poorer outcome in ten cancers including TCGA-GBMLGG, TARGET-LAML, TCGA-LUAD, TCGA-KIRP, TCGA-KIPAN, TCGA-LIHC, TCGA-BLCA, TCGA-UVM, TCGA-ACC and TCGA-KICH.